Back
AbbVie Stock Price Chart
See What One Ticker... One Trade... EVERY WEEK...Can Do for YOU
Show me one ticker payouts.
Buy
66
ABBV
AbbVie
Last Price:
148.14
Seasonality Move:
10.16%
7 Day Trial
ALL ACCESS PASS
$
7
Big Gains Still to Be Had in 2023
Grab a FREE ticket right now on this page!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing slight buying pressure.
AbbVie Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 147.36 | Buy |
| 20-day SMA: | 149.39 | Sell |
| 50-day SMA: | 143.6 | Buy |
| 200-day SMA: | 150.49 | Sell |
| 8-day EMA: | 147.91 | Buy |
| 20-day EMA: | 147.94 | Buy |
| 50-day EMA: | 145.99 | Buy |
| 200-day EMA: | 146.9 | Buy |
AbbVie Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.63 | Buy |
| Relative Strength Index (14 RSI): | 53.2 | Buy |
| Chaikin Money Flow: | 324657 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (147.52 - 151.04) | Sell |
| Bollinger Bands (100): | (136.61 - 153.43) | Buy |
AbbVie Technical Analysis
| Aug 21 | Aug 22 | Aug 23 | Aug 24 | Aug 25 | Aug 28 | Aug 29 | Aug 30 | Aug 31 | Sep 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for AbbVie Stock
Is AbbVie Stock a Buy?
- AbbVie share price is 148.20 while ABBV 8-day simple moving average is 147.36, which is a Buy signal.
- The stock price of ABBV is 148.20 while AbbVie 20-day SMA is 149.39, which makes it a Sell.
- AbbVie 50-day simple moving average is 143.60 while ABBV share price is 148.20, making it a Buy technically.
- ABBV stock price is 148.20 and AbbVie 200-day simple moving average is 150.49, creating a Sell signal.
ABBV Technical Analysis vs Fundamental Analysis
AbbVie Stock Info
Market Cap:
261.58B
Price in USD:
148.20
Share Volume:
3.31M
AbbVie 52-Week Range
52-Week High:
168.11
52-Week Low:
130.96
Buy
66
AbbVie (ABBV)
is a Buy
AbbVie Share Price Forecast
-
What is the AbbVie stock price today?
The AbbVie stock price is 148.20 USD today. -
Will ABBV stock go up or go down?
AbbVie> share price is forecast to RISE/FALL based on technical indicators -
Is AbbVie overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, AbbVie is not overvalued.
Is AbbVie Stock a Buy?
- AbbVie share price is 148.20 while ABBV 8-day exponential moving average is 147.91, which is a Buy signal.
- The stock price of ABBV is 148.20 while AbbVie 20-day EMA is 147.94, which makes it a Buy.
- AbbVie 50-day exponential moving average is 145.99 while ABBV share price is 148.20, making it a Buy technically.
- ABBV stock price is 148.20 and AbbVie 200-day simple moving average is 146.90, creating a Buy signal.
Fundamental Analysis of AbbVie
Is AbbVie a good investment?
- Analysts estimate an earnings decrease this quarter of $0.43 per share, an increase next quarter of $0.05 per share, a decrease this year of $2.71 per share, and an increase next year of $0.05 per share.
Technical Analysis of AbbVie
Should I short AbbVie stock?
- ABBV Moving Average Covergence Divergence (MACD) indicator is 0.63, suggesting AbbVie is a Buy
- AbbVie Relative Strength Index (RSI) is 53.2, which suggest AbbVie is overbought
- The Bollinger Bands (25) for AbbVie is (147.52 - 151.04), which suggest AbbVie is a Buy
- The Bollinger Bands (100) for AbbVie is (136.61 - 153.43), which suggest AbbVie is a Buy
* AbbVie stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.